Intravenous immunoglobulins and transforming growth factor β [8]

Lancet

Volumn 351, Issue 9111, 1998, Pages 1288-

  Van Schaik, I N ^a   Vermeulen, M ^a   Brand, A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; NEUTRALIZING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNE DISEASE; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LETTER; LYMPHOCYTE PROLIFERATION; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL;

EID: 18144437795     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)79354-5     Document Type: Letter

References (5)

1. J Kekow D Reinhold T Pap S Ansorge Intravenous immunoglobulins and transforming growth factor β Lancet 351 1998 184 185
2. IN Van Schaik I Lundkvist M Vermeulen A Brand Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro J Clin Immunol 12 1992 1 10
3. UG Anderson L Bjork U Skansen-Saphir JP Andersson Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG Immunology 79 1993 211 216
4. S Klaesson O Ringdén L Markling M Remberger I Lundkvist Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitro Scand J Immunol 38 1993 477 484
5. D Amran H Renz G Lack K Bradley EW Gelfand Suppression of cytokine-dependent human T-cell proliferation by intravenous immunoglobulin Clin Immunol Immunopathol 73 1994 180 186